Treatment of osteonecrosis of the femoral head in lymphoma patients by free vascularised fibular grafting.
The purpose of this study was to assess the outcomes of treatment of femoral head osteonecrosis using free vascularised fibular grafting in patients with Hodgkin's disease and non-Hodgkin's lymphoma. We retrospectively reviewed seven patients (14 hips) with lymphoma who underwent free vascularised fibular grafting for osteonecrosis of the femoral head, evaluating pre- and postoperative Harris hip scores, visual analog scale (VAS) pain scores, hip range of motion and radiographs. Patients were followed up for a minimum of 1.5 years (mean, 3.3 years). All these patients exhibited good recovery without severe life-threatening complications. The mean Harris hip score improved from 69 to 88, while average VAS pain score decreased from 54 to 18. At the latest follow-up, we found improvement or unchanged radiographs in all three hips with initial Steinberg stage II osteonecrosis and in nine of 11 hips with stage III or IV osteonecrosis. No hips failed treatment and underwent total hip arthroplasty. The clinical data demonstrated that free vascularised fibular grafting can slow or even halt progression of necrosis, and improve the function of the hip and quality of life in lymphoma patients.
Yin
Si
S
Department of Orthopaedic Surgery, Shanghai Jiao Tong University, Shanghai Sixth People's Hospital, Shanghai, China.
Zhang
Changqing
C
Jin
Dongxu
D
Chen
Shengbao
S
Sun
Yuan
Y
Sheng
Jiageng
J
D000293:Adolescent; D000328:Adult; D016025:Bone Transplantation / Q000379:methods*; D005260:Female; D005271:Femur Head Necrosis / Q000209:etiology / Q000503:physiopathology / Q000601:surgery*; D005360:Fibula / Q000098:blood supply / Q000637:transplantation*; D006304:Health Status; D006621:Hip Joint / Q000503:physiopathology / Q000601:surgery; D006801:Humans; D008223:Lymphoma / Q000150:complications / Q000503:physiopathology / Q000601:surgery*; D008297:Male; D008875:Middle Aged; D011474:Prosthesis Design; D011788:Quality of Life; D020127:Recovery of Function; D012189:Retrospective Studies; D012720:Severity of Illness Index; D016896:Treatment Outcome; D055815:Young Adult
J Clin Oncol. 1989 Nov;7(11):1630-6
2809679
Clin Orthop Relat Res. 2001 May;(386):106-13
11347822
J Bone Joint Surg Am. 2003 Jun;85(6):987-93
12783992
Eur J Cancer. 2007 Mar;43(4):683-9
17169552
BMC Musculoskelet Disord. 2007 Aug 08;8:78
17686144
Hematol Oncol. 1995 May-Jun;13(3):131-7
7622143
Eur J Clin Invest. 2000 Mar;30(3):215-21
10691998
Clin Orthop Relat Res. 2008 May;466(5):1117-24
18357495
J Bone Joint Surg Am. 1996 Jul;78(7):1032-8
8698720
Cancer. 1981 Jun 15;47(12):2793-7
7260869
Clin Orthop Relat Res. 1986 Jun;(207):209-15
3720087
J Bone Joint Surg Br. 1995 Jan;77(1):34-41
7822393
Clin Oncol (R Coll Radiol). 2001;13(2):130-4
11373876
J Orthop Sci. 2004;9(6):566-70
16228672
Clin Orthop Relat Res. 2009 Jun;467(6):1522-8
18648898
Int Orthop. 2009 Feb;33(1):41-7
17992527
Microsurgery. 2005;25(4):305-9
15880465
J Bone Joint Surg Am. 1991 Oct;73(9):1357-64
1918119
Emerg Med (Fremantle). 2003 Oct-Dec;15(5-6):441-6
14992058
Arch Orthop Trauma Surg. 2000;120(5-6):241-4
10853887
Clin Orthop Relat Res. 2008 May;466(5):1133-40
18330663
Clin Lab Haematol. 1994 Mar;16(1):3-8
8039344
Orthop Clin North Am. 2007 Jan;38(1):13-22, v
17145291
Ann Rheum Dis. 2003 Oct;62(10):935-8
12972470